Rensair’s patented air purification technology, which combines H13 HEPA filtration with germicidal UVC light, was developed to meet the strict standards of Scandinavian hospitals and is independently validated by scientific research laboratories. It is now trusted by hospitals around the world, in every hemisphere.
Today, Rensair air purifiers are used broadly throughout the healthcare sector, including:
Primary Care: general practitioners and dental surgeries
Hospitals: especially in
Care homes, hospices and assisted living facilities
Rensair meets the standards for air cleaners recommended by leading authorities including the World Health Organization, CDC, SAGE and EPA.
Rensair is proud to be an Associate Member of the NHS Confederation and supports their aim by providing education and expertise on hospital-grade air purification to combat airborne viruses and bacteria. As a result, we hope to improve infection control standards across the NHS and facilitate a return to full capacity, thereby reducing the backlog caused by the pandemic.
Covid-19 has been devastating for hospitals around the world. In the UK, the NHS has been operating at a vastly reduced capacity due to infection control measures. As a result, it could take up to five years to clear the backlog. With further potential waves caused by new variants, waiting times could extend even further.
We now know that the biggest risk of Covid transmission is airborne, while the risk of surface transmission is very low (just a 1 in 10,000 probability, according to the Centers for Disease Control). However, many NHS Trusts struggle to meet the NHS’s own ventilation guidelines of 6 air changes per hour in wards. This so-called ‘structural under-ventilation’ is mainly due to inadequate existing ventilation systems in older hospitals and prohibitive retrofit costs, not to mention the disruption that a new HVAC installation would entail.
Rensair’s portable, hospital grade HEPA filter air purifiers can be a quick fix, supplementing existing integrated ventilation systems to eradicate air contaminants. High performance (min 99.97% efficacy), cost-effective (fraction of the cost of a new HVAC system) , multi-tasking (viruses, bacteria, allergens), and instant to instal (simply plug and play).
The WHO recommends air purifiers to supplement integrated ventilation systems while the UK SAGE committee, in its November 2020 report on air cleaning devices to combat SARS-CoV-2 transmission, recommends two air purifier technologies: fibrous HEPA filter and germicidal UVC light. This is supported by a new report on infection resilient environments, commissioned by the UK government’s Chief Scientific Adviser and published by the Royal Academy of Engineering.
Rensair’s medical grade air purifiers use a patented combination of HEPA filtration and UVC – supported by a powerful fan – to both trap and destroy viruses, rendering the HEPA filter totally safe for easy maintenance.
di origine naturale
poiled foods, kitchens, bathrooms
provenienti da tappeti, finestre e/o porte aperte
moist places, bathrooms, inside pillows, humidifier
Pannelli installati nei soffitti, incubatori, impianti di ventilazione difettosi
diesel and petrol emissions
da mobili e tappeti
provenienti da animali, pavimenti e tappeti
pelle, mucose, suolo
derivanti da cibo bruciato, immondizia, tabacco, prodotti per la pulizia
skin, hair, soil, plastic, clothing
Originally developed to meet the strict requirements of Scandinavian hospitals, Rensair’s medical grade air purifiers are fast becoming the preferred choice for the NHS, a breath of fresh air boosting indoor air quality throughout, from wards to operating theatres.
Rensair has worked closely with NHS Estates teams and NHS Infection Prevention and Control teams at various Trust hospitals on their implementation of our products. This has led to reopening of poorly ventilated closed wards, reduced fallow times between appointments and increased patient throughput in many departments
One Trust was quoted £140,000 per ward to increase the airflow of their existing HVAC system to meet the official guidelines. They decided that buying Rensair’s portable air purifiers was both a significantly cheaper, less disruptive and technically superior air quality solution.
Rensair is the only air purification company to be an Associate Member of the NHS Confederation, supporting their aim by providing education and expertise on air purification to combat airborne viruses and bacteria. As a result, we hope to improve infection control standards across the NHS and facilitate a return to full capacity, tackling the backlog caused by the pandemic.
Rensair’s air purifiers are independently validated by scientific research laboratories, including Eurofins, Norconsult, and Oslo University Hospital.
In a test by the Danish Technological Institute to determine Rensair’s performance in reducing the concentration of MS2 bioaerosols as a proxy for SARS-CoV-2, a particle reduction rate of 99.98% was recorded in 15 minutes and above 99.99% in 30 minutes. Furthermore, a second test reported 100% elimination of virus particles on the filter, with zero traces detected.
Rensair’s medical grade air purifier has also been included in Newsweek’s list of Best Infection Prevention Products 2021, judged by the Leapfrog Group on: effectiveness; safety; successful real-world implementation; the quality of research studies demonstrating the product’s effectiveness; and the stability of the company (to support future implementations).
The impact of Covid on the NHS has been devastating and it has now been reported that it could take up to five years to clear the backlog. People are calling for a bold, transformative approach to resolve this crippling issue. Clearly, a raft of measures is needed, both financial and operational. If the health sector is to live long term with Covid, it needs to cover all the bases: not just the complex issues like human resources and capacity increases, but simpler issues too – like hospital grade air purifiers to remove air contaminants and improve indoor air quality… more
Of course, Covid is not the only threat that can be quelled with clean air. We can predict what will happen with drug-resistant bacteria and we know that it requires a multi-faceted defence system that includes air purifiers to deliver clean air.
Norovirus is a case in point. With particles approximately 27-38 microns in diameter, which are easily trapped by HEPA filters, it is known to spread in aerosol droplets that are created when infected children or adults vomit and/or have diarrhea. Despite that knowledge, preventative measures still focus on fomite cleaning and hand washing, even though, globally, norovirus results in a total of $4.2 billion in direct health system costs and $60.3 billion in societal costs per year… more
Rensair air purifiers are widely used by the NHS to close the gap between the required air change rate to protect health and that delivered by hospital HVAC systems.
Hospital grade air purifiers are not classified as medical devices and are therefore not subject to regulation.